Clinical trial
Varenicline for "Gradual" vs. "Abrupt" Smoking Cessation in Low-motivated COPD Smokers: A Randomized Pilot Study
NCT02894957 is registered in ClinicalTrials.gov with Shaare Zedek Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Varenicline for "Gradual" vs. "Abrupt" Smoking Cessation in Low-motivated COPD Smokers: A Randomized Pilot Study
- Lead sponsor
- Shaare Zedek Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2019
- Completion date
- December 31, 2019
- Enrollment
- 250 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
smoking cessation